If you liked this article you might like

Analysts' Actions -- AMD, Clovis, ConocoPhillips, Disney, Transocean and More
Biotech Stock Mailbag: Why Clovis Oncology Is Trading Lower on Rubraca Study Update
Tesaro Resorts to PR Razzle Dazzle to Make Ovarian Cancer Drug Appear Cheaply Priced
Shortened FDA Advisory Panel Is Bad Omen for Puma Bio's Controversial Breast Cancer Drug